Trial Profile
Safety and Immunogenicity of booster dose of a Hexavalent Vaccine SHAN6 (DTwP-HepB-Hib-IPV) with or without co-administration of MMR vaccine in Toddlers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2020
Price :
$35
*
At a glance
- Drugs Hib-DTP-hepatitis B-poliovirus vaccine (Primary) ; Measles mumps and rubella virus vaccine
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
- Focus Adverse reactions
- Sponsors Shantha Biotechnics
- 14 Jul 2020 Status changed from recruiting to completed.
- 27 Feb 2017 New trial record